We are live on ! Find out more
MDCXW

Medicus Pharma Warrant

5 hedge funds and large institutions have $167K invested in Medicus Pharma Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.01% less ownership

Funds ownership: 17.54%17.53% (-0.01%)

12% less capital invested

Capital invested by funds: $190K → $167K (-$23.1K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
+$4.67K

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$12.4K

MDCXW Hedge Fund Activity: Q4 2025 in Review

5 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q4 2025, worth a combined $167K — down 12% from $190K a quarter earlier.

Fund positioning in MDCXW was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Private Advisor Group, adding an estimated $4.67K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $12.4K sold.

  • 5 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $167K of Medicus Pharma Warrant stock for Q4 2025, down 12% quarter-over-quarter.
  • 1 fund opened new Medicus Pharma Warrant positions in Q4 2025 and 1 closed out, a net change of 0 holders.
  • The largest Medicus Pharma Warrant buyer in Q4 2025 was Private Advisor Group, an estimated $4.67K added.
  • The largest Medicus Pharma Warrant seller in Q4 2025 was Warberg Asset Management, an estimated $12.4K sold.

Based on aggregated 13F filings for Q4 2025.